Oncology R&D spend has been the highest among all of the therapeutic areas for a good part of the last decade. As a result, we have seen the introduction of some ground-breaking therapies that have brought significant gains in cure and survival rates.

However, the net effect cost of cancer care is growing exponentially and is predicted to reach unsustainable levels. The focus is now on medical technologies and device innovations to bring much-needed evolution in the way new drugs are developed and the way patients are treated.

This seminar focuses on the medical device technologies and innovations with potential to bring grassroots changes in cancer research and the care delivery model. We will provide our perspective on how these change catalysts can impact patient experience, cost burdens and reimbursement models.

Media downloads

M1 Disruption of the care pathway in oncology.pdf
Harshal Shah
Vice President, Global MedTech